Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Clinical trial NCT01518465 · TERMINATED

Trial details

NCT number: NCT01518465
Sponsor: University of Southern California
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma

Start date: 2012-01-09
Primary completion: 2016-12-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.